IN8bio, Inc. Common StockINAB

IN8bio is a clinical-stage biopharmaceutical company developing T cell and T cell engager (TCE) product candidates to address unmet medical needs. T cells are a specialized population of T cells that possess unique properties, including the ability to differentiate between healthy and diseased tissue. The Company's pipeline is anchored by INB-600, a novel T cell engager platform with potential applications across oncology and autoimmune.

in8bio.com